TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -0 | 2 | 5 | 21 | 37 | 114 | 30 |
| S | %wins | 100 | 33 | 0 | 0 | 0 | 0 | 22 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/13 20:57 | 4/29/13 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Ryan Stephen J | CA | D | M.d | 0 | 0.00 | 33 | 4 | 9 | 52 | D | 68 | 37 | 20 | 22 | 16 | 7 | 7 | 3 | 0 | 1 | 16 | 27 | 46 | 97 | |
3/6/13 17:35 | 3/5/13 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Ryan Stephen J | CA | D | M.d | 345 | 60.60 | 33 | 6 | 14 | 48 | D | 55 | 44 | 5 | -2 | 1 | 1 | 4 | 2 | 0 | 4 | 10 | 38 | 58 | 159 | |
3/6/13 17:35 | 3/5/13 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Ryan Stephen J | CA | D | S.d | -627 | 110.00 | 33 | -6 | -11 | 48 | D | 55 | 44 | 5 | -2 | 1 | 1 | 4 | 2 | 0 | 4 | 10 | 38 | 58 | 159 | |
1/16/13 17:47 | 1/15/13 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Ryan Stephen J | CA | D | M.d | 345 | 60.60 | 33 | 6 | 14 | 48 | D | 64 | 37 | 11 | -2 | -3 | -6 | 0 | -3 | 0 | 1 | 2 | 15 | 44 | 114 | |
1/16/13 17:47 | 1/15/13 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Ryan Stephen J | CA | D | S.d | -589 | 103.30 | 33 | -6 | -11 | 48 | D | 64 | 37 | 11 | -2 | -3 | -6 | 0 | -3 | 0 | 1 | 2 | 15 | 44 | 114 | |
8/7/12 20:58 | 8/3/12 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Ryan Stephen J | CA | D | M.dm | 2,213 | 47.28 | 33 | 47 | 999% | 48 | D | 92 | 24 | 37 | 6 | 10 | 2 | 2 | 1 | -1 | 0 | 4 | 10 | 10 | 69 | |
8/7/12 20:58 | 8/3/12 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Ryan Stephen J | CA | D | S.dm | -4,013 | 85.76 | 33 | -47 | -49 | 48 | D | 92 | 24 | 37 | 6 | 10 | 2 | 2 | 1 | -1 | 0 | 4 | 10 | 10 | 69 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |